About Casein kinase II subunit alpha
Casein kinase II subunit alpha (CSNK2A1) is a protein
from Homo sapiens identified by UniProt accession
P68400, 391 residues long.
MolForge cross-references it against 0 known binders and
121 disease associations.
Target properties
| Protein name | Casein kinase II subunit alpha |
| UniProt accession | P68400 |
| Gene | CSNK2A1 |
| Organism | Homo sapiens |
| Length | 391 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (10)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (121)
Diseases linked to this target (Open Targets).
- Okur-Chung neurodevelopmental syndrome · score 0.76
- neurodegenerative disease · score 0.52
- genetic disorder · score 0.50
- neuroinflammatory disorder · score 0.44
- complex neurodevelopmental disorder · score 0.37
- syndromic intellectual disability · score 0.37
- Neurodevelopmental delay · score 0.34
- breast adenocarcinoma · score 0.27
- low grade glioma · score 0.27
- autism spectrum disorder · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P68400-F1 | alphafold | PREDICTED | 88.94 | — |
Amino-acid sequence (391 residues)
MSGPVPSRAR VYTDVNTHRP REYWDYESHV VEWGNQDDYQ LVRKLGRGKY SEVFEAINIT NNEKVVVKIL KPVKKKKIKR EIKILENLRG GPNIITLADI VKDPVSRTPA LVFEHVNNTD FKQLYQTLTD YDIRFYMYEI LKALDYCHSM GIMHRDVKPH NVMIDHEHRK LRLIDWGLAE FYHPGQEYNV RVASRYFKGP ELLVDYQMYD YSLDMWSLGC MLASMIFRKE PFFHGHDNYD QLVRIAKVLG TEDLYDYIDK YNIELDPRFN DILGRHSRKR WERFVHSENQ HLVSPEALDF LDKLLRYDHQ SRLTAREAME HPYFYTVVKD QARMGSSSMP GGSTPVSSAN MMSGISSVPT PSPLGPLAGS PVIAAANPLG MPVPAAAGAQ Q
Explore Casein kinase II subunit alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets